Medigen Vaccine Biologics Corp (高端疫苗) is planning to develop its next-generation COVID-19 vaccine by using a sequence of the Beta variant of SARS-CoV-2, which was first detected in South Africa, the company said in a statement on Thursday.
The company’s animal tests showed that a booster shot built on the Beta variant prompted immunity in hamsters against all variants of the virus, it said.
Medigen is seeking to conduct human trials for the vaccine in Taiwan, but it would not necessarily need to conduct phase 1 clinical trials, the earliest stage involving human testing, company spokesman Leo Lee (李思賢) told the Taipei Times by telephone on Friday.
Photo: Billy H.C. Kwok, Bloomberg
The drugmaker would consult with the local drug regulator regarding the protocol for the next round of clinical trials, Lee said.
Medigen in May conducted research on whether a third dose of its current vaccine would bolster immunity against the original SARS-CoV-2 virus, the company said.
It administered the doses to 45 participants six months after they received the first two shots, the firm said.
In separate trials on hamsters, the drugmaker tested their immune response to other major variants after receiving three doses, it said.
Medigen said it split the research into five sub-trials: In the first, it gave hamsters two shots developed on the original virus; in the second, it gave them two shots developed on the Beta variant; in the third, it gave “bivalent” vaccines containing both strains; in the fourth, it gave three shots developed on the original virus; and in the fifth, it gave two shots developed on the original virus and an additional shot developed on the Beta variant.
Hamsters in all five groups developed antibodies, while those given a third shot, whether based on the original virus or the Beta variant, had higher antibody levels than those that received only two shots, the company said.
Hamsters that were given two shots developed on the original virus and a third shot based on the Beta variant developed the highest antibody levels, regardless of whether they were infected with the Alpha, Beta, Gamma or Delta variants, the company said.
Viral loads in the lungs and nasal cavities of the hamsters of that group reduced significantly eight weeks after receiving the third shot, it added.
Medigen shares gained 1.65 percent to NT$278 in Taipei trading on Friday.
The stock price has risen 169.9 percent so far this year, Taipei Exchange data showed.
In Italy’s storied gold-making hubs, jewelers are reworking their designs to trim gold content as they race to blunt the effect of record prices and appeal to shoppers watching their budgets. Gold prices hit a record high on Thursday, surging near US$5,600 an ounce, more than double a year ago as geopolitical concerns and jitters over trade pushed investors toward the safe-haven asset. The rally is putting undue pressure on small artisans as they face mounting demands from customers, including international brands, to produce cheaper items, from signature pieces to wedding rings, according to interviews with four independent jewelers in Italy’s main
Japanese Prime Minister Sanae Takaichi has talked up the benefits of a weaker yen in a campaign speech, adopting a tone at odds with her finance ministry, which has refused to rule out any options to counter excessive foreign exchange volatility. Takaichi later softened her stance, saying she did not have a preference for the yen’s direction. “People say the weak yen is bad right now, but for export industries, it’s a major opportunity,” Takaichi said on Saturday at a rally for Liberal Democratic Party candidate Daishiro Yamagiwa in Kanagawa Prefecture ahead of a snap election on Sunday. “Whether it’s selling food or
CONCERNS: Tech companies investing in AI businesses that purchase their products have raised questions among investors that they are artificially propping up demand Nvidia Corp chief executive officer Jensen Huang (黃仁勳) on Saturday said that the company would be participating in OpenAI’s latest funding round, describing it as potentially “the largest investment we’ve ever made.” “We will invest a great deal of money,” Huang told reporters while visiting Taipei. “I believe in OpenAI. The work that they do is incredible. They’re one of the most consequential companies of our time.” Huang did not say exactly how much Nvidia might contribute, but described the investment as “huge.” “Let Sam announce how much he’s going to raise — it’s for him to decide,” Huang said, referring to OpenAI
The global server market is expected to grow 12.8 percent annually this year, with artificial intelligence (AI) servers projected to account for 16.5 percent, driven by continued investment in AI infrastructure by major cloud service providers (CSPs), market researcher TrendForce Corp (集邦科技) said yesterday. Global AI server shipments this year are expected to increase 28 percent year-on-year to more than 2.7 million units, driven by sustained demand from CSPs and government sovereign cloud projects, TrendForce analyst Frank Kung (龔明德) told the Taipei Times. Demand for GPU-based AI servers, including Nvidia Corp’s GB and Vera Rubin rack systems, is expected to remain high,